Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Deterioration
Direction inferred from the company’s description.Scale
-10.4
% (year-on-year change in revenue)Wording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)2023年3月1日〜2023年8月31日ConsolidatedJapanese GAAPNet Sales40,992¥ millionYear on year -10.4%Progress 46.6%
Operating profit9,952¥ millionYear on year -9.0%Progress 46.0%
Ordinary income13,878¥ millionYear on year -17.9%Progress 64.4%
Net income attributable to owners of the parent9,835¥ millionYear on year -20.5%Progress 62.6%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share558円24銭
Financial position at period-end
Total assets148,807¥ million
of which net assets 90,113 ¥ millionEquity ratio 55.7%vs. prior year-end +1.8pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueSemiconductor and FPD Equipment Business ¥40,839 million (YoY -10.4%), Life Sciences Business ¥152 million (YoY -17.6%)
Segment profitSemiconductor and FPD Equipment Business ¥10,297 million (YoY -9.5%), Life Sciences Business ¥-97 million
Regional sales¥4,805 million, ¥6,598 million, ¥9,520 million, ¥3,981 million, ¥12,024 million, ¥4,062 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥88,026 million (YoY -6.9%)
Operating profit¥21,619 million (YoY -18.2%)
Ordinary income¥21,553 million (YoY -29.0%)
Net income¥15,718 million (YoY -26.5%)
Revision to Earnings ForecastNo revision
Annual Dividend Forecast¥135 → ¥135（0.0%）
Factors Behind Changes in Business Performance
メモリ半導体の世界的な需要減速に伴う一時的な在庫調整や設備投資の先送りの影響を受けた。一方、第2四半期には主に中国向け及び米国向けで需要が回復基調となった。
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥2 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥6 million
Orders received and order backlogOrders received ¥40,437 million (YoY +69.8%) / Order backlog ¥64,174 million (YoY +96.2%)
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Institutional investors and analysts
Issued Shares at Period-End17,640,000 Shares
Treasury Shares at Period-End19,791 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2023年3月1日〜2023年8月31日 |
| Net Sales | ¥40,992 million (YoY -10.4%) |
| Operating profit | ¥9,952 million (YoY -9.0%) |
| Ordinary income | ¥13,878 million (YoY -17.9%) |
| Profit attributable to owners of the parent | ¥9,835 million (YoY -20.5%) |
| Net income per share | 558円24銭 |
| Equity ratio | End of the current fiscal period 55.7 / End of previous period 53.9 |
| Total assets | ¥148,807 million |
| Net assets | ¥90,113 million |
| Full-year earnings forecast | Net Sales ¥88,026 million (YoY -6.9%) / Operating profit ¥21,619 million (YoY -18.2%) / Ordinary income ¥21,553 million (YoY -29.0%) / Net income ¥15,718 million (YoY -26.5%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥135 → ¥135（0.0%） |
| Segment revenue | Semiconductor and FPD Equipment Business ¥40,839 million (YoY -10.4%), Life Sciences Business ¥152 million (YoY -17.6%) |
| Segment profit | Semiconductor and FPD Equipment Business ¥10,297 million (YoY -9.5%), Life Sciences Business ¥-97 million |
| Regional sales | ¥4,805 million, ¥6,598 million, ¥9,520 million, ¥3,981 million, ¥12,024 million, ¥4,062 million |
| Orders received and order backlog | Orders received ¥40,437 million (YoY +69.8%) / Order backlog ¥64,174 million (YoY +96.2%) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥2 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥6 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts |
| Issued Shares at Period-End | 17,640,000 Shares |
| Treasury Shares at Period-End | 19,791 Shares |
| Factors Behind Changes in Business Performance | メモリ半導体の世界的な需要減速に伴う一時的な在庫調整や設備投資の先送りの影響を受けた。一方、第2四半期には主に中国向け及び米国向けで需要が回復基調となった。 |
Items this document does not state (10)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyDepreciation and amortizationImpairment lossMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.半導体需要の減速に伴う在庫調整や設備投資の先送りの影響を受けた。一方、第2四半期には主に中国向け及び米国向けで需要が回復基調となった。経常利益は為替の影響も受けた。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.